Thursday, 3 April 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 3 April 2025
Ascott/IQVIA
Ascott/IQVIA
49 submissions on PBAC's desk

The PBAC has dropped the agenda for its upcoming July meeting with 49 submissions on the table of which 14 cover innovative drugs seeking their first PBS listing.

Top drugs chase bigger markets
Change to listing submissions for big name drugs seeking new indications and expanded populations
TODAY
Discontinued vax for dementia?
Australian experts weigh in on a new Standford University study that could have 'profound' implications
TODAY
Drugs quietly listed on the PBS
While the Albanese Government has been drip-feeding PBS listings ahead of the election, there were still some surprises this month
2 April New to the PBS
TGA greenlights 17 new drug uses
Big drugs grow even bigger, scoring multiple new uses while others have beaten their rivals to new indications
1 April
Biggest ever pharma tax dodge?
This company sold US$20 billion worth of drugs to American patients in a year yet paid zero US tax
1 April
Company relocates to CBD office
Natural light, green spaces, high indoor quality and a 6-star green rating, creates a space for the team to thrive
31 March
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (20)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (5)

Executive Roles (1)

Other (17)

Lifeline arrives for world's top drug
With a patent cliff looming, results from a pivotal Phase 3 trial could see this cancer drug remain a blockbuster for much longer
2 April
New brand targets US expansion
Aussie pharma announces compounded version of ED nasal spray as the original product goes through FDA approval
2 April
High-flyers face off again
Familiar names in pharma legal counsel nominated for prestigious awards... and it's not their first time. See who's in the running
2 April
Aussie boss nails $1.6B Novo deal
Brokers lucrative agreement with Danish pharma giant for a pre-clinical drug targeting a novel obesity pathway
2 April
New player joins PBC market
Company celebrates TGA approval of innovative product as it awaits the PBAC's decision from the March meeting
1 April
Fast listing for GSK's Aussie drug
Bone marrow cancer drug discovered in Melbourne took just four months to win subsidy after TGA approval
1 April
$96.3M PBS drug wins expansion
First targeted treatment option to be reimbursed for Australians living with a rare, unpredictable and debilitating autoimmune disease
1 April
Novo pioneers Aussie pharma first
Establishes council to improve the health of Aboriginal and Torres Strait Islander people living with diabetes and obesity
31 March
Butler ambushed over PBS drugs
Good news about PBS co-pay sours under TV grilling about the PBS failing Australia's sickest citizens
31 March
Flagship drug wins PBS expansion
Earlier, broader listing will see more than 115,000 additional Australians eligible for treatment to prevent cardiovascular death
31 March
TGA approves seven new drugs
New medicines registered by AstraZeneca, Amgen, Chiesi, Ipsen, Reach Pharmaceuticals, and Roche
31 March Approvals Action
AbbVie sues over stolen 'shortcut'
Claims trade secrets and confidential information were stolen by ex-employees to develop antibody-drug conjugates
28 March
GM departs for new plum job
ICYMI: From ANZ lead to another senior role at a much bigger company plus other popular stories this week
28 March
Aussie direct-to-patient model lifts off
Company uses doctor-developed platform to connect HCPs and patients for diagnosis and treatment
28 March
PiF advertise
PiF advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.